flox/flox Mice The lox modified Slc17a6 (Vglut2) targeting construct was constructed using a mouse 129 BAC genomic clone and recombineering technology (Lee et al., 2001) . A PCR amplicon containing Lox P-Kan-Lox P sequence flanked by 70 bps of homologous sequence at each end, which matched sites in the first intron of Vglut2, was generated using the following primers: VGLUT2UPHF, 5' aaatatcaaa aaataccagt cttgttgaaa gatagctatt accttctacc ccattctttc ataaaaatgg GCGCGCCTAGTCGACTTCGA 3' and VGLUT2UPHR, 5' gacttggaat gctgaatggg cttgaaaaaa acggtggtgc tgttctgatg ctagcacatc catgaaatgt ACTCGAGCCCTTAATTAACCGGG 3', and the following DNA as the template: plasmid pSV-Cre. This amplified product was electroporated into EL350 cells (Lee et al., 2001 ) bearing the Vglut2 BAC genomic clone and correctly targeted clones were identified. The Kan cassette was then removed by inducing expression of crerecombinase, leaving one lox P site in the first intron. The modified BAC was then transferred to EL250 cells (Lee et al., 2001) . A second PCR amplicon containing Lox P-FRT-Kan-FRT sequence flanked by 70 bps of homologous sequence at each end, which matched sites in the second intron of Vglut2, was generated using the following primers: VGLUT2DOWNHUF, 5' tgtagtagag ctgcttgatt tggtcacaga atttggggac acatggaaa gccgaactga cttttctgag GCTCAGAACTAGTGGATCCA 3' and VGLUT2DOWNHR, 5' catgcccagg aaactgggca tgcgattttt ccctcttgaa aatttcctgg gtatcttggg ctccagaaag GGTATCGATAAGCTTATATCGA 3', and the following DNA as the template: plasmid pL451. This amplified product was then electroporated into the EL250 cells containing the modified Vglut2 BAC and correctly targeted clones were identified. A targeting construct for electroporation into mouse ES cells was then derived from the modified BAC. The targeting construct spanned from 4 kb upstream of the intron 1 lox P site to 4 kb downstream of the intron 2 lox P site, and was lifted out of the modified BAC using a PCR amplified plasmid vector (pCR-BLUNT, Invitrogen, Carlsbad, CA) which was flanked, at its ends, by 70 bps of sequence which was homologous to the desired 5' and 3' ends of the targeting construct (i.e. 4 kb above and 4 kb below the upstream and downstream lox sites,
respectively). The resulting targeting construct was then linearized and electroporated into a 129 mouse embryonic stem (ES) cells (W4/129S6, Taconic, NY). Drug selection was applied and correctly targeted clones were identified and then injected into blastocysts which resulted in a number of 100% male chimeras. The male chimeras were then breed to female mice bearing a flp-recombinase transgene (ROSA-Flp: stock number 003946 from The Jackson Lab, Bar Harbor, ME) to remove the neo/kan cassette flanked by FRT sites, which is inserted in intron 2 of the Vglut2 locus. The resulting Vglut2 flox/+ offspring were then used for further studies.
Generation of SF1-Cre;Vglut2 flox/flox Mice Sf1-Cre transgenic mice (FVB/N background) (Dhillon et al., 2006) were mated with Vglut2 flox/+ mice (129, C57Bl/6 background) and a breeding colony was maintained by mating Sf1-Cre;Vglut2 flox/flox mice with Vglut2 flox/flox mice. 50% of offspring from such mating were controls (i.e. Vglut2 flox/flox mice) and 50% lacked VGLUT2 in SF1 neurons (i.e. Sf1-Cre;Vglut2 flox/flox mice). Only littermates of such matings were used as study subjects to avoid any potential confounding effects of mixed genetic background. Vglut2 flox/flox mice were genotyped by PCR using primers spanning either the intron 1 loxP site (UPF: 5′-GTC TAC TGT AAG TGA AGA CAC, and UPR, 5′-CTT TAG GCT TTC ATC CTT GAG 3') or the intron 2 lox P site (DOWNF: 5'CCT GAG CGA AGG TGA GCT GAA-3' and DOWNR: 5'-CCA AAT ACC TGA AAG TTA CTG-3').
High-Fat, High-Sucrose Diet Study
Groups of 8-10 week old male controls (Vglut2 flox/flox mice) and Sf1-Cre;Vglut2 flox/flox mice were switched to the high fat, high sucrose diet (HFD, Research Diets, D12331, 58% kcal from fat, 26% from sucrose, 5.557kcal/gm) and maintained on HFD for 12 weeks. Body weight and food intake were monitored weekly. On the first 3 days of starting the HFD study, oxygen consumption was measured by indirect calorimetry. Individual housed mice were placed at room temperature (22 0 C-24 0 C) in chambers of a Comprehensive Lab Animal Monitoring System (CLAMS, Columbus Instruments, Columbus, OH). Food and water were provided ad libitum. Mice were acclimatized in the chambers for 48 hr prior to data collection. After the end of HFD study, the mice were anesthetized for dual-energy X-ray absorptiometry (MEC LunarCorp. Minster OH) to measure fat mass and lean mass.
Electrophysiologic Recordings on Autaptic Cultured Neurons
Micro-punched VMH tissues were collected from young adult mice (4-6 weeks of age) and were digested using a papain dissociation system (Worthington, Lakewood, NJ). Cells were seeded on poly-L-lysine-coated glass coverslips in Neurobasal A medium (Invitrogen, Grand Island, NY) supplemented with 1x B27 0.4 mM L-glutamine, and 1% fetal calf serum. Glutamic acid (25 µM) was added for the initial plating. The neurons were planted at low density to encourage the formation of autosynapses. The media were replenished every 3-5 d, and whole-cell recordings were made between days 7 and 14 in culture.
The recording bath solution contained (in mM) NaCl 137, KCl 5.6, HEPES 10, MgCl 2 4, CaCl 2 4, glucose 10 (pH 7.35 with KOH). Electrodes had resistances of 2.5 -4 MΩ when filled with the KCl internal solution, which contained (in mM) KCl 115, NaCl 20, HEPES 5, EGTA 0.1, MgCl 2 1.5, Mg-ATP 2, and Na-GTP 0.5 (pH 7.35 with KOH). 0.1% lucifer yellow was included in pipette solution to confirm the presence of autosynapses. Synaptic currents were recorded in whole-cell voltage clamp mode and release of synaptic vesicles was evoked by a depolarizing pulse to +10 mV from the holding potential of -60 mV, applied every 20 sec. EPSCs and IPSCs were identified by their deferent decay time constants and by using specific glutamate receptor antagonists (QBNX and D-APV) and GABA receptor antagonist (bicuculline).
In Situ Hybridization Studies
A Vglut2 riboprobe corresponding to exon 2, a Slc17a7 (Vglut1) riboprobe corresponding to a 600 bp-segment of 3' UTR and a Slc17a8 (Vglut3) probe corresponding to a 250 bp-segment of the last exon were used for in situ hybridization studies. The sequences chosen for generating probes show least homology among these 3 Vgluts. The primers used for Vglut2 probe were 5' ttggccccgggaaagagg 3' and 5' agcagtatcgcagccccaaag 3'; for Vglut1 probe 5' gacttccactccatacacctc 3' and 5' ctggacaatgattgtactaagc 3'; and for Vglut3 prober 5' gaactcaaccacgagacttt 3' and cagttgtaagctgaggtgaagccaga 3'. The 35 S-labeled cRNA probes were prepared and the in situ hybridizations were performed as previously described (Kishi et al., 2003) .
Glucose Homeostasis Studies
Fed blood glucose levels were measured between 9am-10am and fasted blood glucose levels were obtained 24 hours after removing food at 9am on the previous day. At the same time, liver samples were obtained for quantitative PCR analysis of gene expression and blood was collected for preparation of plasma.
For i.c.v. injections, female animals were anesthetized and placed in a stereotaxic apparatus. A stainless steel cannula (30 gauge) was implanted in the right lateral ventricle according to the following mouse brain coordinates: 0.5 mm posterior to the bregma, 1.3 mm lateral to midline, and 2.1 mm below the surface of the skull. The animals were then allowed to recover for 3 days. Correct placement of cannulas was confirmed by intensive water intake after injection of neurotensin (1 ug/3µl). On the test day, 2-deoxyglucose (1mg/3µl/mouse) or saline was injected i.c.v. into fed mice. At 30 minutes after injection, blood and liver samples were collected.
Glucose was measured from tail vein blood using a glucose meter (Roche Diagnostics Corp.) or was determined by the Infinity glucose oxidation method (Thermo Electron, Melbrone, Australia). Glucagon was measured by radioimmunoassay (Linco Research Inc.), insulin by enzymatic immunoassay (Crystal Chem. Inc., Downers Grove, IL) using plasma in the presence of 1 ug/ml aprotinin and 1 mM EDTA.
Quantitative PCR Assay
RNA was extracted from mouse liver using the Trizol Reagent (Invitrogen, Life Technologies, Carlsbad, CA). Liver RNA was reverse transcribed with RETROscript (Ambion, Inc., Austin, TX) and amplified using Assay on Demand Tagman probes and primers (Applied Biosystems, Foster City, CA). The assay ID for Ppargc1α (PGC1α) is Mm01208836_g1; for Pck1 (PEPCK) is Mm01247059_g1 and for G6pc (G6Pase) is Mm00839363_m1. Relative expression of mRNA was determined using standard curves based on liver cDNA, and samples were adjusted for total RNA content by 18S ribosomal RNA or GAPDH quantitative PCR (Applied Biosystems, Foster City, CA). Quantitative PCR was performed on an Mx4000 instrument (Stratagene). Assays were linear over five orders of magnitude.
Hyperinsulinemic-Hypoglycemic Clamp Studies
The hyperinsulinemia hypoglycemia protocol was a modification of a procedure previously described for rats (McCrimmon et al., 2006) . Basically one week before each study, all animals were anesthetized with an intraperitoneal injection (1 ml/kg) of a mixture of xylazine (AnaSed, 20 mg/ml; Lloyd Laboratories, Shenandoah, IA) and ketamine (Ketaset, 100 mg/ml; Aveco, Fort Dodge, IA) in a ratio of 1:2 (vol:vol) before undergoing vascular surgery for the implantation vascular catheters in a jugular vein. After 1 week of recovery, the animals were studied after a 6 hour fast. On the morning of the study, the vascular catheters were opened and maintained patent by a slow infusion of saline 3.3 µl/min). A hyperinsulinemic-hypoglycemic clamp technique, as adapted for the mice, was used to provide a standardized hypoglycemic stimulus. flox/flox mice. As previously reported, Vglut3 is expressed selectively in the raphei nucleus (E) (Schafer et al., 2002) . Scale bar=100 µM. 
